Connect your AI

Celldex Therapeutics CLDX Price / sales

Price / sales at other companies

Eli LillyLLY

11.4×-3.8×

PfizerPFE

2.5×+0.2×

Rogers CorporationROG

2.3×+0.8×

AmgenAMGN

5.1×+0.2×

Regeneron PharmaceuticalsREGN

5.5×+0.6×

IncyteINCY

3.5×+0.8×

Other financials

Income statement

Revenue$15.0K-97.8%

Operating income-$84.4M-34.6%

Net income-$78.7M-46.3%

EPS (diluted)-$1.18-45.7%

Balance sheet

Cash & equivalents$35.7M+109%

Total debt$1.9M-44.3%

Total equity$456.2M-35.1%

Total assets$511.3M-30.9%

Cash flow

Operating cash flow-$65.6M-20.6%

CapEx$1.6M+518%

Free cash flow-$67.2M-23.0%

Valuation

Market cap$2.59B+75.2%

Enterprise value$2.55B+74.4%

Profitability

Operating margin-35,688.5%-39,114pp

Net margin-32,753.6%-35,519pp

FCF margin-26,125.8%-28,907pp

Returns & leverage

Return on equity-48.9%-498pp

Debt / equity0×0.0×

Current ratio8.9×-12.7×

Where this comes from

Calculated from Celldex Therapeutics’s reported figures.

market cap/total revenue=2,438.2×

Based on the most recent quarter.

The official record: Celldex Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Celldex Therapeutics's price / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Celldex Therapeutics's price / sales?: Celldex Therapeutics (CLDX) reported price / sales of 2,438.2× in Q1 2026.
How has Celldex Therapeutics's price / sales changed year-over-year?: Celldex Therapeutics's price / sales increased by 1429.7% year-over-year, from 159.4× to 2,438.2×.
What is the long-term trend for Celldex Therapeutics's price / sales?: Over 5 years (2020 to 2025), Celldex Therapeutics's price / sales has grown at a 60.3% compound annual growth rate (CAGR), from 110.2× to 1,167.4×.
What does price / sales mean?: Market capitalization at the quarter end divided by trailing-twelve-month revenue. The price the market pays for each dollar of sales.